Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 2,261–2,280 of 18,047 drug recalls

Drug Recall Terminated Historical recordClass II

Florbetaben F-18 (Neuraceq¿) Injection Solution 1.4 to 135 mCi/mL, 50 mL in 1 multi-dose glass vial, Diagnostic-For Intravenous Use Only, Manufactured by SOFIE Co dba SOFIE, Dulles, VA 20166 for Life Molecular Imagining Ltd., NDC 54828-001-50

by Sofie Co dba Sofie

Reason
Lack of Assurance of Sterility: out-of-specification test results observed for Filter Integrity Test (FIT).
Recall initiated
August 22, 2023
Reported by FDA
October 4, 2023
Distribution
Product was released to one facility in VA.

View recall →

Drug Recall Ongoing Historical recordClass II

Humanrace Suncare, Ozone Body Protection Cream, Broad Spectrum Sunscreen SPF 30, packaged as a 148mL (5 fl oz.) bottle, PA ++++, 100% mineral, Active Ingredient: Zinc oxide 15%, Snow Mushroom, Squalene, Aloe, Dist. By: @Humanrace 2022 Beverly Hills, CA 90210, USA, NDC 82779-002

by HUMANRACE

Reason
Subpotent Drug: Product does not contain SPF that is declared on the label.
Recall initiated
August 18, 2023
Reported by FDA
September 27, 2023
Distribution
Nationwide in the USA, Spain, Italy, UK, and France.

View recall →

Drug Recall Ongoing Historical recordClass II

Humanrace Suncare, Ozone Face Protection Daily Moisturizer, Broad Spectrum Sunscreen SPF 30, packaged as a 53mL (1.8 fl oz.) bottle, 100% mineral, Active Ingredient: Zinc oxide 15%, Snow Mushroom, Dist. By: @Humanrace 2022 Beverly Hills, CA 90210, USA, NDC 82779-01

by HUMANRACE

Reason
Subpotent Drug: Product does not contain SPF that is declared on the label.
Recall initiated
August 18, 2023
Reported by FDA
September 27, 2023
Distribution
Nationwide in the USA, Spain, Italy, UK, and France.

View recall →

Drug Recall Ongoing Historical recordClass I

SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936, NDC 0078-0110-22.

by Novartis Pharmaceuticals Corp.

Reason
Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals.
Recall initiated
September 8, 2023
Reported by FDA
September 27, 2023
Distribution
Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass III

Kroger Mint Burst ANTISEPTIC MOUTH RINSE ANTIGINGIVITIS/ANTIPLAQUE (Eucalyptol 0.092%, menthol 0.042%, Methyl salicylate 0.06%, thymol 0.064%), packaged in 16.9 FL OZ (500 mL) bottle, DISTRIBUTED BY THEKROGER CO. CINCINNATI, OHIO 45202, UPC 011110380807

by Vi-Jon, LLC

Reason
Incorrect/Undeclared Excipients.
Recall initiated
September 5, 2023
Reported by FDA
September 27, 2023
Distribution
The consignee list includes one distributor with seven distribution centers. No product was sold under government contract. No product was sold to any federal, state, or local agency in the school lunch program.

View recall →

Drug Recall Terminated Historical recordClass III

Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-506-96

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Subpotent: Out of Specification result observed for low assay
Recall initiated
September 7, 2023
Reported by FDA
September 27, 2023
Distribution
Nationwide wide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Rasagiline Tablets 0.5mg, 30-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A., NDC 0378-1270-93

by Aurobindo Pharma USA Inc.

Reason
Failed dissolution specifications - results obtained were below spec average.
Recall initiated
August 2, 2023
Reported by FDA
September 27, 2023
Distribution
USA nationwide

View recall →

Drug Recall Completed Historical recordClass II

BD ChloraPrep Clear, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Sterile Solution, 0.03mL (1 ml) each, 60 applicators in carton, applicator is sterile if package is intact. CareFusion 213, LLC, El Paso, TX 79912, subsidiary of Becton, Dickinson and Co., NDC 54365-400-31 REF 930480 Product is packaged in the following manner: There is one (1) sterile applicator (sponge) per pouch. Each inner carton contains sixty (60) pouches. There are four (4) inner cartons per shipping case (total of 240 pouches per case).

by CareFusion 213, LLC

Reason
Stability data does not support expiry: Shelf-life of the impacted lots of BD ChloraPrep" Clear 1 mL Applicator cannot be substantiated beyond 12-months although labeled with 36-month expiry. Stability studies indicate that the impacted lots, if stored at 30¿C/75% relative humidity continuously beyond 12 months, may exhibit growth of Aspergillus penicillioides.
Recall initiated
August 25, 2023
Reported by FDA
September 27, 2023
Distribution
Distributed nationwide to 100 consignees. Please refer to consignee list.

View recall →

Drug Recall Ongoing Historical recordClass II

octiq Lubricating Eye Drops, Dextran 70.01%, Hypromellose 0.3%, 0.5 FL OZ Each (2X 15 mL Bottles), Manufactured for Innovus Pharmaceuticals, Inc., Englewood, CO 80112, Made in Jordan, NDC:57483-610-15.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Drug Recall Ongoing Historical recordClass II

TRP Natural Eyes, Twitching Relief, Sterile Eye Ointment, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-099-15.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Drug Recall Ongoing Historical recordClass II

TRP Natural Eyes, Stye Relief, Sterile Eye Ointment, Homeopathic 0.14 oz (4 grams), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-014-13.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Drug Recall Ongoing Historical recordClass II

TRP Natural Eyes, Red Eye Relief PF, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502 NDC: 17312-095-19.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Drug Recall Ongoing Historical recordClass II

TRP Natural Eyes, Red Eye Relief, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-058-15.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Drug Recall Ongoing Historical recordClass II

TRP Natural Eyes, Pink Eye Relief PF, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502 NDC: 17312-094-19.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Drug Recall Ongoing Historical recordClass II

TRP Natural Eyes, Pink Eye Relief, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502 NDC: 17312-013-15.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Drug Recall Ongoing Historical recordClass II

MAJOR LubriFresh P.M. Nighttime Ointment, Lubricant Eye Ointment, Sterile, 0.125 OZ (3.5g), Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268, Made in Jordan, NDC: 0904-6488-38.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Drug Recall Ongoing Historical recordClass II

TRP Natural Eyes, Floaters Relief, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-098-15.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Drug Recall Ongoing Historical recordClass II

TRP Natural Eyes, Eye Lid Relief, Sterile Eye ointment, Homeopathic 0.14 oz (4 grams), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-165-13.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Drug Recall Ongoing Historical recordClass II

TRP Natural Eyes, Eye Lid Relief PF, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-417-19.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Drug Recall Ongoing Historical recordClass II

TRP Natural Eyes, Dryness Relief PF, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-096-19.

by AMMAN PHARMACEUTICAL INDUSTRIES

Reason
Lack of Assurance of Sterility
Recall initiated
September 1, 2023
Reported by FDA
September 27, 2023
Distribution
Product was distributed to two (2) direct accounts in RI and CO.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.